307 related articles for article (PubMed ID: 31308088)
1. A Cross-Reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-Mediated Acute Otitis Media.
Rowe HM; Mann B; Iverson A; Poole A; Tuomanen E; Rosch JW
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308088
[TBL] [Abstract][Full Text] [Related]
2. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.
Mann B; Thornton J; Heath R; Wade KR; Tweten RK; Gao G; El Kasmi K; Jordan JB; Mitrea DM; Kriwacki R; Maisonneuve J; Alderson M; Tuomanen EI
J Infect Dis; 2014 Apr; 209(7):1116-25. PubMed ID: 24041791
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
[TBL] [Abstract][Full Text] [Related]
4. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
Hammitt LL; Campbell JC; Borys D; Weatherholtz RC; Reid R; Goklish N; Moulton LH; Traskine M; Song Y; Swinnen K; Santosham M; O'Brien KL
Vaccine; 2019 Dec; 37(51):7482-7492. PubMed ID: 31629570
[TBL] [Abstract][Full Text] [Related]
6. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
[TBL] [Abstract][Full Text] [Related]
7. Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media.
Vermee Q; Cohen R; Hays C; Varon E; Bonacorsi S; Bechet S; Thollot F; Corrard F; Poyart C; Levy C; Raymond J
BMC Infect Dis; 2019 Jan; 19(1):44. PubMed ID: 30634919
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal vaccine and otitis media.
Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
[TBL] [Abstract][Full Text] [Related]
9. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Bertot GM; Becker PD; Guzmán CA; Grinstein S
J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
[TBL] [Abstract][Full Text] [Related]
11. Otitis media: prospects for prevention.
Haggard M
Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
[TBL] [Abstract][Full Text] [Related]
12. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
13. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
[TBL] [Abstract][Full Text] [Related]
14. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
[TBL] [Abstract][Full Text] [Related]
15. [Acute otitis media in the era of pneumococcal vaccination].
Baquero-Artigao F; del Castillo F
Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):505-9. PubMed ID: 19094865
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
Murphy TF
Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
[TBL] [Abstract][Full Text] [Related]
17. Evolving microbiology of complicated acute otitis media before and after introduction of the pneumococcal conjugate vaccine in France.
Dupont D; Mahjoub-Messai F; François M; Doit C; Mariani-Kurkdjian P; Bidet P; Bonacorsi S; Carol A; Bingen E
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):89-92. PubMed ID: 20727478
[TBL] [Abstract][Full Text] [Related]
18. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
Xu Q; Pryharski K; Pichichero ME
Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628
[TBL] [Abstract][Full Text] [Related]
19. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
[TBL] [Abstract][Full Text] [Related]
20. Experimental recurrent otitis media induced by Haemophilus influenzae: protection and serum antibodies.
Melhus A; Hermansson A; Akkoyunlu M; Forsgren A; Prellner K
Am J Otolaryngol; 1995; 16(6):383-90. PubMed ID: 8572254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
